Janus Clinical Trials Repository (CTR) An Update
|
|
|
- Griffin Parrish
- 10 years ago
- Views:
Transcription
1 Janus Clinical Trials Repository (CTR) An Update Armando Oliva, M.D. Associate Director for Informatics CDER Office of Computational Science U.S. Food and Drug Administration
2 The views expressed in this presentation are those of the speaker and not necessarily those of the Food and Drug Administration
3 Outline Background History of the Janus CTR Current State Looking Ahead Janus CTR Look and Feel
4 Background FDA has the largest repository in the world of subject-level clinical trial data But data are largely unstructured, poorly accessible, multiple formats Akin to a data land-fill rather than a modern, data repository Tremendous opportunity to improve our scientific knowledge about medical products, and the science of medical product development FDA Science Board Report (2007) FDA Science and Mission at Risk The FDA must invest in the development of large-scale, sustainable data sharing infrastructures that can support clinical trials and pharmacovigilance (page K-11 Recommendation 4)
5 What is Janus CTR? Replace data land-fill with a Modern data warehouse to improve CDER s management and analysis of clinical trial data CTR is a standards-based infrastructure that supports the receipt, validation, storage, easy access and analysis of study data CTR intends to Enhance scientific computing Improve scientific knowledge Inform regulatory decisions Improve public health and patient safety
6 What is Janus? The Name Knowledge Janus n : (Roman mythology) the Roman god of doorways, passages and beginnings; is depicted with two faces on opposite sides of his head, one looking towards the past and the other looking towards the future. Data
7 Janus CTR Conceptual Overview Interaction with Sponsor (Phase 1, 2, 3) Sponsor submits standardized study data to CDER CDER runs data quality checks and loads into CTR Janus CTR Support for: Analysis, Data Prep, Training Analysis Tools Data are accessed through CTR User Interface Technology Standard Analysis Panels Search Download
8 Janus CTR Milestones Will Janus survive? Phase 1 NCI Phase 2 NCI ARRA Funding Begin Phase 3 NCI Phase 3 NCI *White Oak Data Center Diabetes Legacy Data Conversion Migration to FDA WODC* Limited Production JumpStart Pilot Data Curation Module (Sept) Full Production
9 Current State Janus CTR is operational at the White Oak Data Center (WODC) as of January 2015 CTR contains, as of mid March 2015: Production Environment 61 studies Test Environment 19 studies Numbers steadily increasing
10 CTR Look and Feel Web-based User Interface Evolving as user preferences/feedback are collected Study Browser search studies Download analysis-friendly datasets Demographics and treatment assignment info in each record Numeric dates with level of precision noted (e.g. time unknown ) Suppqual information merged with parent domain Units converted to U.S. conventional units Full MedDRA hierarchy added to all MedDRA Preferred Terms Query Builder build custom datasets to answer specific scientific, research, public health questions, especially across multiple studies Standard Analysis Panels (demographics, adverse events, hepatic laboratory data, etc.)
11
12
13 Search User can search by any SDTM Trial Summary (TS) parameter TS data are critical for CTR Search to function properly
14 Study Browser
15 Standard Analysis Panels
16 Standard Analysis Panels -- Demographics
17 Query Builder Create Custom Datasets
18 Feedback Form
19 How Does CTR Help the Reviewer? Reviewers can Locate and download clinical trial data in an analysisfriendly format Pool data across studies within an application for integrated analyses Execute a panel of standard analyses designed with the clinical review template in mind (e.g. demographics) Create custom datasets to answer specific scientific or public health questions. This Query function enables pooling data across studies, advanced filtering, and downloading the data to their desktops
20 CTR Operational Pilot and JumpStart CTR is currently in an operational pilot Only JumpStart studies are being loaded CTR undergoing user acceptance testing JumpStart is CDER s award winning program to jump start the regulatory review process Applications are enrolled in the JumpStart program: 30 marketing applications targeted for 2015 Pivotal trials of these applications are stored in CTR
21 Summary Janus CTR is operational at FDA 2015 Operational Pilot 2016 Full Production CTR is transforming how CDER manages and analyzes clinical trial data
22 Armando Oliva, M.D.
ADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA
ABSTRACT: ADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA Over the past few years, the United States Food
USE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE
USE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE Kalyani Chilukuri, Clinovo, Sunnyvale CA WUSS 2011 Annual Conference October 2011 TABLE OF CONTENTS 1. ABSTRACT... 3 2. INTRODUCTION...
Using SAS Data Integration Studio to Convert Clinical Trials Data to the CDISC SDTM Standard Barry R. Cohen, Octagon Research Solutions, Wayne, PA
Using SAS Data Integration Studio to Convert Clinical Trials Data to the CDISC SDTM Standard Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT A new industry standard for clinical trials data,
Classifying Adverse Events From Clinical Trials
Classifying Adverse Events From Clinical Trials Bernard LaSalle, Richard Bradshaw University of Utah, Biomedical Informatics, Salt Lake City, UT USA [email protected] Abstract The use of adverse
Update From the Office of Surveillance and Epidemiology
Update From the Office of Surveillance and Epidemiology Gerald J. Dal Pan, MD, MHS Director Office of Surveillance and Epidemiology Center for Drug Evaluation and Research Presentation to FDA-CMS Summit
4. Executive Summary of Part 1 FDA Overview of Current Environment
Public Meeting Regulatory New Drug Review: Solutions for Study Data Exchange Standards 1. Background Meeting Summary Food and Drug Administration White Oak, MD November 5, 2012 10am 4pm On November 5,
Guidance for Industry
Reprinted from FDA s website by EAS Consulting Group, LLC Guidance for Industry Providing Regulatory Submissions in Electronic Format Standardized Study Data DRAFT GUIDANCE This guidance document is being
Einführung in die CDISC Standards CDISC Standards around the World. Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14.
Einführung in die CDISC Standards CDISC Standards around the World Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14. März 2015 1 Outline Overview of CDISC Therapeutic Area Standards SHARE Metadata
Optimizing Safety Surveillance During Clinical Trials Using Data Visualization Tools
Optimizing Safety Surveillance During Clinical Trials Using Data Visualization Tools Laura McKain, M.D., Medical Director, Pharmacovigilance; Tammy Jackson, Director, Preclarus Development, Clinical Innovation;
Paper-less Reporting: On-line Data Review and Analysis Using SAS/PH-Clinical Software
Paper-less Reporting: On-line Data Review and Analysis Using SAS/PH-Clinical Software Eileen Ching, SmithKline Beecham Pharmaceuticals, Collegeville, PA Rosemary Oakes, SmithKline Beecham Pharmaceuticals,
STUDY DATA TECHNICAL CONFORMANCE GUIDE
STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions
Use of standards: can we really be analysis ready?
Standards in analysis & reporting Use of standards: can we really be analysis ready? Analysis ready? Why? Reducing time to market/approval Reducing time to delivery Reducing re work Designing subsequent
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject
Medical Dictionary for Regulatory Activities (MedDRA) Update
Medical Dictionary for Regulatory Activities (MedDRA) Update International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Topics MedDRA as an ICH
Did you know? Accenture can deliver business outcome-focused results for your life sciences research & development organization like these:
How can Accenture Accelerated R&D BPO Services help you achieve greater business value? Did you know? Accenture can deliver business outcome-focused results for your life sciences research & development
Training/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program
Training/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program Domain Clinical Data Sciences Private Limited 8-2-611/1/2, Road No 11, Banjara Hills, Hyderabad Andhra Pradesh
Business & Decision Life Sciences What s new in ADaM
Business & Decision Life Sciences What s new in ADaM Gavin Winpenny 23 rd June 2015 Agenda What s happening CDISC and Regulatory Submission Landscape ADaM Implementation Guide ADaM Data Structures for
ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC
Paper CD01 ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC Joerg Guettner, Bayer Pharma AG, Wuppertal, Germany Alexandru Cuza, UCB Biosciences GmbH, Monheim,
PharmaSUG2010 - Paper CD13
PharmaSUG2010 - Paper CD13 In-Depth Review of Validation Tools to Check Compliance of CDISC SDTM-Ready Clinical Datasets Bhavin Busa, Cubist Pharmaceuticals, Inc., Lexington, MA Kim Lindfield, Cubist Pharmaceuticals,
Avg cost of a complex trial $100mn. Avg cost per patient for a Phase III Study
1 Industry Perspective Over the last several years, clinical research costs have sky rocketed while new drug approvals are at multi-year lows. Studies have become global in nature and more complex to manage
What is Clinical Data Management
What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,
Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies- Small Entity Compliance Guide
Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies- Small Entity Compliance Guide U.S. Department of Health and Human Services Center for Drug Evaluation and
The Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data. Ravi Shankar
The Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data Ravi Shankar Open access to clinical trials data advances open science Broad open access to entire clinical
Organization Profile. IT Services
Introduction In today s scientific and medical world, various issues in clinical trials and research have permeated every society and every field in medicine. Ethics and in particular the quality of research
Talking your Language. E-WorkBook 10 provides a one-platform, single source of truth without adding complexity to research
Talking your Language E-WorkBook 10 provides a one-platform, single source of truth without adding complexity to research Meet E-WorkBook 10 In January 2015 we launched E-WorkBook 10 - the next step in
Implementation of SDTM in a pharma company with complete outsourcing strategy. Annamaria Muraro Helsinn Healthcare Lugano, Switzerland
Italian-Speaking CDISC User Group 2008 Implementation of SDTM in a pharma company with complete outsourcing strategy Annamaria Muraro Helsinn Healthcare Lugano, Switzerland Background Full outsourcing
Data Standards in Clinical Trials, A Regulatory Perspec9ve
Data Standards in Clinical Trials, A Regulatory Perspec9ve NIH Data Standards Forum: Maximizing Innova8on by Standardizing Mary Ann Slack Center for Drug Evalua9on and Research (CDER) U.S. Food and Drug
codebeamer INTLAND SOFTWARE codebeamer Medical ALM Solution is built for IEC62304 compliance and provides a wealth of medical development knowledge
codebeamer Medical ALM Solution is built for INTLAND Traceability matrix Medical wiki Risk management IEC 62304 compliance codebeamer INTLAND codebeamer Medical ALM Solution is built for Medical Device
Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL
Innovative Medicines Technological Platform Udo Siegmann member of e3c, CDISC Sen. Dir. Acc. Management PAREXEL Facts about PAREXEL Full service CRO (Clinical Research Organisation) Involved in more than
SAS CLINICAL TRAINING
SAS CLINICAL TRAINING Presented By 3S Business Corporation Inc www.3sbc.com Call us at : 281-823-9222 Mail us at : [email protected] Table of Contents S.No TOPICS 1 Introduction to Clinical Trials 2 Introduction
Environmental Health Science. Brian S. Schwartz, MD, MS
Environmental Health Science Data Streams Health Data Brian S. Schwartz, MD, MS January 10, 2013 When is a data stream not a data stream? When it is health data. EHR data = PHI of health system Data stream
STUDY DATA TECHNICAL CONFORMANCE GUIDE
STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions
A white paper presented by: Barry Cohen Director, Clinical Data Strategies Octagon Research Solutions, Inc. Wayne, PA
THE CLINICAL DATA AND REGULATORY EXPERTS SDTM, Plus or Minus A white paper presented by: Barry Cohen Director, Clinical Data Strategies Octagon Research Solutions, Inc. Wayne, PA This Whitepaper is for
Adopting Site Quality Management to Optimize Risk-Based Monitoring
Adopting Site Quality Management to Optimize Risk-Based Monitoring Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective
POLICY AND PROCEDURES OFFICE OF STRATEGIC PROGRAMS. CDER Master Data Management. Table of Contents
POLICY AND PROCEDURES OFFICE OF STRATEGIC PROGRAMS CDER Master Data Management Table of Contents PURPOSE...1 BACKGROUND...1 POLICIES...2 RESPONSIBILITIES...2 PROCEDURES...4 REFERENCES...5 DEFINITIONS...5
Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management
Written Notice of Participation by the Clinical Data Interchange Standards Consortium (CDISC) and Written Statement for Discussion Topics to be Addressed In the FDA Public Hearing: Electronic Submission
How to search the EU Clinical Trials Register
28 April 2014 Information and Communications Technology Contents Contents... 1 1. Searching the EU Clinical Trials Register... 1 1.1. Basic search... 2 1.2. Search for multiple words (AND operator)...
CURESEARCH FOR CHILDREN S CANCER AND GATEWAY FOR CANCER RESEARCH COMMUNITY IMPACT AWARD - CLINICAL TRIALS
KEY DATES Request for Applications Opens: June 3, 2015 Application Due: August 3, 2015 Award Notification: September 2015 Award Period : October 2015 October 2016 CURESEARCH FOR CHILDREN S CANCER AND GATEWAY
SBI2013: Building BI Solutions using Excel and SharePoint 2013
UNDERSTANDING MICROSOFT'S BI TOOLSET 3 DAYS SBI2013: Building BI Solutions using Excel and AUDIENCE FORMAT COURSE DESCRIPTION Business Analysts and Excel Power Users Instructor-led training with hands-on
EudraVigilance stakeholder change management plan
26 October 2015 EMA/797114/2014 Information Management Division Consultation of Project Maintenance Group 1 15 July 2015 Consultation of Eudravigilance Expert Working Group 23 September 2015 Consultation
Roadmap for study startup
How-To Guide Roadmap for study startup Deploying Adobe technology to automate clinical study startup procedures Section 1: Introduction and overview 2 1.1 Introduction 2 1.2 Overview of the clinical study
Course duration: 45 Hrs Class duration: 1-1.5hrs
Course duration: 45 Hrs Class duration: 1-1.5hrs USA : +1 9099998808 India : +91-9986411022 mail : [email protected] SAP BO 4.0 Introduction Data warehouse concepts Difference between Versions
Development of CDISC Tuberculosis Data Standards
Development of CDISC Tuberculosis Data Standards Michael Fiola Senior Director / Quintiles The presenters have disclosed that they have no proprietary or financial interests in the topics covered in this
STUDY DATA TECHNICAL CONFORMANCE GUIDE
STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions
Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission
, October 24-26, 2012, San Francisco, USA Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission Abstract In this article, the relationship between the Statistical Analysis Plan
How to Create Dashboards. Published 2014-08
How to Create Dashboards Published 2014-08 Table of Content 1. Introduction... 3 2. What you need before you start... 3 3. Introduction... 3 3.1. Open dashboard Example 1... 3 3.2. Example 1... 4 3.2.1.
Use of MedDRA in CTCAE and in the Biopharmaceutical Industry
Use of MedDRA in CTCAE and in the Biopharmaceutical Industry Ann Setser, BSN, MEd MedDRA MSSO MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations
Vertex Investigator-Initiated Studies Program Overview
Vertex Investigator-Initiated Studies Program Overview Our Goal To support independent, investigator-initiated research designed to advance scientific knowledge of disease states, patient populations,
Big Data and Text Mining
Big Data and Text Mining Dr. Ian Lewin Senior NLP Resource Specialist [email protected] www.linguamatics.com About Linguamatics Boston, USA Cambridge, UK Software Consulting Hosted content Agile,
Providing Regulatory Submissions In Electronic Format Standardized Study Data
Providing Regulatory Submissions In Electronic Format Standardized Study Data Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
Clinical Trial Protocol Development. Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group
Clinical Trial Protocol Development Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group Objectives The clinical trial protocol is the heart of any
Informatics Resources for Clinical Research. Jim Cimino, Geoff Gordon, Matt Wyatt and James Willig UAB Informatics Institute April 6, 2016
Informatics Resources for Clinical Research Jim Cimino, Geoff Gordon, Matt Wyatt and James Willig UAB Informatics Institute April 6, 2016 Today s Take-Home Messages Overview of the clinical informatics
PharmaSUG 2016 Paper IB10
ABSTRACT PharmaSUG 2016 Paper IB10 Moving from Data Collection to Data Visualization and Analytics: Leveraging CDISC SDTM Standards to Support Data Marts Steve Kirby, JD, MS, Chiltern, King of Prussia,
M2074 - Designing and Implementing OLAP Solutions Using Microsoft SQL Server 2000 5 Day Course
Module 1: Introduction to Data Warehousing and OLAP Introducing Data Warehousing Defining OLAP Solutions Understanding Data Warehouse Design Understanding OLAP Models Applying OLAP Cubes At the end of
Summary Level Information and Data for CDER s Inspection Planning. Paul Okwesili Office of Scientific Investigations Office of Compliance, CDER/FDA
Summary Level Information and Data for CDER s Inspection Planning Paul Okwesili Office of Scientific Investigations Office of Compliance, CDER/FDA Agenda Summary of OSI Requests CDER Clinical Investigator
End-to-End E-Clinical Coverage with Oracle Health Sciences InForm GTM
End-to-End E-Clinical Coverage with InForm GTM A Complete Solution for Global Clinical Trials The broad market acceptance of electronic data capture (EDC) technology, coupled with an industry moving toward
Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions
Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions U.S. Department of Health and Human Services Food and Drug Administration Center for
Course Catalog. www.airweb.org/academy
www.airweb.org/academy Course Catalog 2015 Hosted by the Association for Institutional Research, Data and Decisions Academy courses provide self-paced, online professional development for institutional
Paper DM10 SAS & Clinical Data Repository Karthikeyan Chidambaram
Paper DM10 SAS & Clinical Data Repository Karthikeyan Chidambaram Cognizant Technology Solutions, Newbury Park, CA Clinical Data Repository (CDR) Drug development lifecycle consumes a lot of time, money
PK IN DRUG DEVELOPMENT. CDISC management of PK data. Matteo Rossini Milan, 9 February 2010
Matteo Rossini Milan, 9 February 2010 Introduction to CDISC CDISC: Clinical Data Interchange Standards Consortium CDISC is a global, open, multidisciplinary, non-profit organization that has established
Visualizing Clinical Trial Data Matt Becker, SAS Institute
Visualizing Clinical Trial Data Matt Becker, SAS Institute ABSTRACT Today, all employees at health and life science corporations may need access to view operational data. There may be visualization needs
Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: [email protected]
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: [email protected] Education: Masters of Science, Healthcare Administration, Capital City University,
Managing Clinical Trials Data using SAS Software
Paper DM08 Managing Clinical Trials Data using SAS Software Martin J. Rosenberg, Ph.D., MAJARO InfoSystems, Inc. ABSTRACT For over five years, one of the largest clinical trials ever conducted (over 670,000
MedDRA in pharmacovigilance industry perspective
MedDRA in pharmacovigilance industry SFDA ICH MedDRA Workshop, Beijing, 13 14 May 2011 Christina Winter, MD, FFPM Medical director GlaxoSmithKline R&D / ICH MedDRA Management Board 2011 ICH International
Breakthrough Therapy Program U.S. Food and Drug Administration (FDA)
Breakthrough Therapy Program U.S. Food and Drug Administration (FDA) Presentation before the European Commission Expert Group on Safe and Timely Access to Medicines for Patients (STAMP) Jarilyn Dupont,
Get More Value from Your Reference Data Make it Meaningful with TopBraid RDM
Get More Value from Your Reference Data Make it Meaningful with TopBraid RDM Bob DuCharme Data Governance and Information Quality Conference June 9 TopQuadrant Company Focus: TopQuadrant was founded in
2. Upon login, landing page should be Home if not, click Home in Navigation Pane (top right).
Overview This document outlines general instructions for using Ohio University s (OBI) system for Institutional Research data. OBI is a web-based reporting system used to support the campus community s
Data Standards and the National Cardiovascular Research Infrastructure (NCRI)
Data Standards and the National Cardiovascular Research Infrastructure (NCRI) A partnership with Duke Clinical Research Institute (DCRI) and the American College of Cardiology Foundation (ACCF) November
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS 29 OCTOBER 2015 DR. DIRK J. EVERS BACKGROUND TreatmentMAP
Clinical Data Management Overview
The 2 nd Clinical Data Management Training Clinical Data Management Overview Andrew Taylor ( 安 泰 乐 ), M.S. Head of Clinical Data Management August 30, 2010 Learning Objectives Overview of Process Related
Copyright 2012, SAS Institute Inc. All rights reserved. VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS
VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS WENJUN BAO AND JASON CHEN JMP, SAS INC. PHUSE, SHANGHAI, NOV 28, 2014 OUTLINES: CDISC Standard SDTM ADaM Interactive Standardized TLFs Tables
Building and Customizing a CDISC Compliance and Data Quality Application Wayne Zhong, Accretion Softworks, Chester Springs, PA
WUSS2015 Paper 84 Building and Customizing a CDISC Compliance and Data Quality Application Wayne Zhong, Accretion Softworks, Chester Springs, PA ABSTRACT Creating your own SAS application to perform CDISC
Webvantage blue Sapphire: Release Notice
Webvantage blue Sapphire: Release Notice New in this Release Desktop Agency Settings Agency Settings is enhanced to improve the workflow and usability. The controls are more intuitive and additional options
Mastering emeasures - Charting a Course To Align Quality And Payment
Mastering emeasures - Charting a Course To Align Quality And Payment a complimentary webinar from healthsystemcio.com, sponsored by Encore Health Resources Housekeeping To ensure you enjoy all the functionality
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance Objectives NCI s Clinical Trials Reporting Program (CTRP) Overview CTRP What is it? CTRP is an NCI mandated
Department of Human Resources
Workforce Services Workforce Policy and Planning Department Management/ Human Resource Information Systems Employee Relations Employment Compensation and Workforce Analysis Employee Benefits Organizational
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences It s not information overload, it s filter failure. Clay Shirky Life Sciences organizations face the challenge
Guidance for Industry
Guidance for Industry Cancer Drug and Biological Products Clinical Data in Marketing Applications U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and
WHITEPAPER MARKETING COMMUNICATION AND CRM
WHITEPAPER MARKETING COMMUNICATION AND CRM WHITEPAPER MARKETING COMMUNICATION AND CRM 2 ABOUT Nowadays, it is essential for a company to have a defined and efficient marketing strategy. Implementing such
Lessons on the Metadata Approach. Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014
1 Lessons on the Metadata Approach Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014 2 Experience Human beings, who are almost unique in having the ability to learn from the experience of
A New MS Consortium for A New MS Clinical Outcome Measure
A New MS Consortium for A New MS Clinical Outcome Measure Nicholas G. LaRocca, Ph.D. Richard Rudick, M.D. Lynn Hudson, Ph.D. Co-Directors, MSOAC American Academy of Neurology March 20 th, 2013 The problem
FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES
SMG 1117.37 FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF HUMAN RESOURCES DIVISION OF HUMAN RESOURCE SERVICES FOR THE OMPT
Understanding Clinical Trial Recruitment Rules
Understanding Clinical Trial Recruitment Rules Richard Klein Patient Liaison Program Director Office of Health and Constituent Affairs Food and Drug Administration CTTI Patient Group and Clinical Trials
CDER/CBER s Top 7 CDISC Standards Issues
CDER/CBER s Top 7 CDISC Standards Issues Dhananjay Chhatre, MS, RAC edata Management Solutions Team Office of Business Informatics CDER, U.S. FDA Amy Malla Review Management CBER, U.S. FDA Background ~
Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER
Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER LT Andrew Fine, Pharm.D., BCPS Safety Evaluator Division of Pharmacovigilance Office of Pharmacovigilance and Epidemiology
ABSTRACT INTRODUCTION PATIENT PROFILES SESUG 2012. Paper PH-07
Paper PH-07 Developing a Complete Picture of Patient Safety in Clinical Trials Richard C. Zink, JMP Life Sciences, SAS Institute, Cary, NC, United States Russell D. Wolfinger, JMP Life Sciences, SAS Institute,
SDTM-ETL 3.1 New Features
SDTM-ETL 3.1 New Features SDTM-ETL 3.1 has a lot of new features. The most important ones are listed and explained in this document which lists all major new features of versions 3.0 and 3.1. Support for
